Effect of the 5-HT2 antagonist ketanserin on the ECT-induced prolactin release.
Zis
A P
AP
Department of Psychiatry, University of British Columbia, Vancouver, Canada.
Manji
H K
HK
Remick
R A
RA
Grant
B E
BE
Clark
C M
CM
D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects; D002986:Clinical Trials as Topic; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D007650:Ketanserin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*; D011985:Receptors, Serotonin / Q000187:drug effects*
D011985:Receptors, Serotonin; D011388:Prolactin; D007650:Ketanserin